UniProt ID | CPSF5_HUMAN | |
---|---|---|
UniProt AC | O43809 | |
Protein Name | Cleavage and polyadenylation specificity factor subunit 5 {ECO:0000303|PubMed:23187700} | |
Gene Name | NUDT21 {ECO:0000312|HGNC:HGNC:13870} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 227 | |
Subcellular Localization | Nucleus . Cytoplasm . Shuttles between the nucleus and the cytoplasm in a transcription- and XPO1/CRM1-independent manner, most probably in complex with the cleavage factor Im complex (CFIm) (PubMed:19864460). In punctate subnuclear structures locali | |
Protein Description | Component of the cleavage factor Im (CFIm) complex that functions as an activator of the pre-mRNA 3'-end cleavage and polyadenylation processing required for the maturation of pre-mRNA into functional mRNAs. [PubMed: 9659921] | |
Protein Sequence | MSVVPPNRSQTGWPRGVTQFGNKYIQQTKPLTLERTINLYPLTNYTFGTKEPLYEKDSSVAARFQRMREEFDKIGMRRTVEGVLIVHEHRLPHVLLLQLGTTFFKLPGGELNPGEDEVEGLKRLMTEILGRQDGVLQDWVIDDCIGNWWRPNFEPPQYPYIPAHITKPKEHKKLFLVQLQEKALFAVPKNYKLVAAPLFELYDNAPGYGPIISSLPQLLSRFNFIYN | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MSVVPPNRS ------CCCCCCCCC | 31.64 | - | |
2 | Phosphorylation | ------MSVVPPNRS ------CCCCCCCCC | 31.64 | 27486199 | |
8 | Methylation | MSVVPPNRSQTGWPR CCCCCCCCCCCCCCC | 35.60 | - | |
9 | Phosphorylation | SVVPPNRSQTGWPRG CCCCCCCCCCCCCCC | 38.44 | 26699800 | |
11 | Phosphorylation | VPPNRSQTGWPRGVT CCCCCCCCCCCCCCC | 42.32 | 26699800 | |
15 | Methylation | RSQTGWPRGVTQFGN CCCCCCCCCCCCCCH | 45.78 | 24129315 | |
18 | Phosphorylation | TGWPRGVTQFGNKYI CCCCCCCCCCCHHEE | 22.47 | 26699800 | |
23 | Methylation | GVTQFGNKYIQQTKP CCCCCCHHEECCCCC | 44.07 | 17172643 | |
23 | Acetylation | GVTQFGNKYIQQTKP CCCCCCHHEECCCCC | 44.07 | 17172643 | |
23 | Ubiquitination | GVTQFGNKYIQQTKP CCCCCCHHEECCCCC | 44.07 | 21906983 | |
23 | 2-Hydroxyisobutyrylation | GVTQFGNKYIQQTKP CCCCCCHHEECCCCC | 44.07 | - | |
24 | Phosphorylation | VTQFGNKYIQQTKPL CCCCCHHEECCCCCE | 14.15 | 28152594 | |
28 | Phosphorylation | GNKYIQQTKPLTLER CHHEECCCCCEEEEE | 20.46 | 26699800 | |
29 | Malonylation | NKYIQQTKPLTLERT HHEECCCCCEEEEEE | 33.42 | 26320211 | |
29 | Acetylation | NKYIQQTKPLTLERT HHEECCCCCEEEEEE | 33.42 | 19608861 | |
29 | Ubiquitination | NKYIQQTKPLTLERT HHEECCCCCEEEEEE | 33.42 | 21890473 | |
36 | Phosphorylation | KPLTLERTINLYPLT CCEEEEEEEEEEECC | 12.58 | - | |
40 | Phosphorylation | LERTINLYPLTNYTF EEEEEEEEECCCCCC | 7.54 | 20090780 | |
43 | Phosphorylation | TINLYPLTNYTFGTK EEEEEECCCCCCCCC | 22.98 | 28152594 | |
45 | Phosphorylation | NLYPLTNYTFGTKEP EEEECCCCCCCCCCC | 9.75 | - | |
46 | Phosphorylation | LYPLTNYTFGTKEPL EEECCCCCCCCCCCC | 20.05 | 29496907 | |
49 | Phosphorylation | LTNYTFGTKEPLYEK CCCCCCCCCCCCCCC | 28.22 | - | |
50 | Ubiquitination | TNYTFGTKEPLYEKD CCCCCCCCCCCCCCC | 58.68 | 21906983 | |
54 | Phosphorylation | FGTKEPLYEKDSSVA CCCCCCCCCCCHHHH | 31.48 | 29496907 | |
56 | Acetylation | TKEPLYEKDSSVAAR CCCCCCCCCHHHHHH | 49.72 | 19608861 | |
56 | Ubiquitination | TKEPLYEKDSSVAAR CCCCCCCCCHHHHHH | 49.72 | 21906983 | |
56 | 2-Hydroxyisobutyrylation | TKEPLYEKDSSVAAR CCCCCCCCCHHHHHH | 49.72 | - | |
73 | Ubiquitination | RMREEFDKIGMRRTV HHHHHHHHHCCCCCE | 46.62 | 19608861 | |
73 | Acetylation | RMREEFDKIGMRRTV HHHHHHHHHCCCCCE | 46.62 | 19608861 | |
101 | Phosphorylation | VLLLQLGTTFFKLPG EEEEECCCCEEECCC | 29.08 | 20068231 | |
102 | Phosphorylation | LLLQLGTTFFKLPGG EEEECCCCEEECCCC | 25.85 | 20068231 | |
122 | Ubiquitination | EDEVEGLKRLMTEIL CHHHHHHHHHHHHHH | 55.10 | 21906983 | |
122 | 2-Hydroxyisobutyrylation | EDEVEGLKRLMTEIL CHHHHHHHHHHHHHH | 55.10 | - | |
122 | Acetylation | EDEVEGLKRLMTEIL CHHHHHHHHHHHHHH | 55.10 | 26051181 | |
125 | Sulfoxidation | VEGLKRLMTEILGRQ HHHHHHHHHHHHCCC | 3.52 | 21406390 | |
126 | Phosphorylation | EGLKRLMTEILGRQD HHHHHHHHHHHCCCC | 25.19 | 28851738 | |
182 | Ubiquitination | FLVQLQEKALFAVPK EEEEHHHHHHHCCCC | 37.11 | 21906983 | |
189 | Ubiquitination | KALFAVPKNYKLVAA HHHHCCCCCCEEEEE | 67.33 | 21890473 | |
189 | Malonylation | KALFAVPKNYKLVAA HHHHCCCCCCEEEEE | 67.33 | 26320211 | |
189 | Acetylation | KALFAVPKNYKLVAA HHHHCCCCCCEEEEE | 67.33 | 19608861 | |
192 | Ubiquitination | FAVPKNYKLVAAPLF HCCCCCCEEEEEEHH | 45.97 | - | |
226 | Phosphorylation | LSRFNFIYN------ HHHCCCCCC------ | 15.64 | 25839225 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CPSF5_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CPSF5_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CPSF5_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-23; LYS-29; LYS-56; LYS-73AND LYS-189, AND MASS SPECTROMETRY. | |
"Multiple histone deacetylases and the CREB-binding protein regulatepre-mRNA 3'-end processing."; Shimazu T., Horinouchi S., Yoshida M.; J. Biol. Chem. 282:4470-4478(2007). Cited for: ACETYLATION AT LYS-23, INTERACTION WITH PAPOLA AND CPSF6, MASSSPECTROMETRY, AND MUTAGENESIS OF LYS-23 AND LYS-29. | |
Phosphorylation | |
Reference | PubMed |
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-40, AND MASSSPECTROMETRY. |